Spyre Therapeutics, Inc.
SYRENASDAQ
Healthcare
Biotechnology
$47.81
+0.23(0.5%)
52W $11.80 – $50.44
Quick:
SCHEDULE 13G/A
Mar 27, 2026 (1 weeks ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Feb 19, 2026 (1 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-K
Feb 19, 2026 (1 months ago)Annual Report
Full-year financial statements and risk factors
YoY revenue/margin trends, new risk disclosures
SCHEDULE 13G/A
Feb 17, 2026 (1 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Jan 12, 2026 (2 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Nov 4, 2025 (5 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-Q
Nov 4, 2025 (5 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
SCHEDULE 13D/A
Oct 17, 2025 (5 months ago)SCHEDULE 13D/A (Amendment)
SEC filing disclosure
Filing details and context
8-K
Oct 15, 2025 (5 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Oct 14, 2025 (5 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Aug 5, 2025 (8 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-Q
Aug 5, 2025 (8 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
SCHEDULE 13G
Jul 29, 2025 (8 months ago)Beneficial Ownership
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G/A
Jul 16, 2025 (8 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Jun 17, 2025 (9 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Jun 2, 2025 (10 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-Q
May 8, 2025 (11 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
8-K
May 8, 2025 (11 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G
May 1, 2025 (11 months ago)Beneficial Ownership
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Mar 6, 2025 (1 years ago)Current Report
Material event disclosure
Event materiality and market reaction